Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

86.07
Delayed Data
As of Feb 24
 +0.34 / +0.40%
Today’s Change
71.46
Today|||52-Week Range
103.73
+16.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.2B580.4M1.0B1.7B
 
 
 
 
 
Cost of Goods Sold81.9M61.0M62.2M210.5M
 
 
 
 
 
Depreciation And Amortization48.4M63.3M62.3M--
 
 
 
 
 
Operating ExpensesGross Income1.1B456.2M907.8M1.5B
 
 
 
 
 
General Expenses1.3B1.1B1.4B1.5B
 
 
 
 
 
Research And Development918.8M855.5M995.9M1.0B
 
 
 
 
 
Total Operating Expenses1.4B1.2B1.5B1.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-199.4M-641.5M-464.7M11.2M
 
 
 
 
 
Extraordinary Charge-704.0M-79.9M-2.2M-1.3M
 
 
 
 
 
Interest Expense On Debt22.7M72.9M84.2M81.4M
 
 
 
 
 
Other Expenses-49.9M59.4M-6.7M4.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-976.1M-734.9M-557.8M-67.4M
 
 
 
 
 
Income Taxes-288.6M-7.0M-30.4M-16.7M
 
 
 
 
 
Minority Interest-242.5M-4.2M-31.8M-28.0M
 
 
 
 
 
Discontinued Operations0.00-912.0K0.00--
 
 
Net Income-445.0M-738.6M-556.3M-112.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.9M235.3M241.3M244.7M
 
 
 
 
 
Shares To Calculate EPS Diluted224.9M235.3M241.3M244.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.98-$3.14-$2.31-$0.46
 
 
 
 
 
EPS Diluted-$1.98-$3.14-$2.31-$0.46